comparemela.com

Latest Breaking News On - Jeffreyl wade - Page 1 : comparemela.com

Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference

Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Texas
United-states
Jeffreyl-wade
Carrie-siragusa
Hc-wainwright-co
Exchange-commission
Nasdaq
Lexicon-pharmaceuticals-inc
Lexicon-pharmaceuticals
Annual-global-investment-conference
Investor-inquiries

Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference

THE WOODLANDS, Texas, Sept. 07, 2023 Lexicon Pharmaceuticals, Inc. today announced its participation in the H.C. Wainwright & Co. 25th Annual Global Investment Conference, taking place.

Texas
United-states
Jeffreyl-wade
Alina-cocuzza
Carrie-siragusa
Lexicon-pharmaceuticals-inc
Globenewswire-inc
Hc-wainwright-co
Exchange-commission
Nasdaq
Lexicon-pharmaceuticals
Investment-conference

Citigroup Trims Lexicon Pharmaceuticals (NASDAQ:LXRX) Target Price to $5.00

Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) had its price target dropped by equities researchers at Citigroup from $8.00 to $5.00 in a report issued on Friday, FlyOnTheWall reports. Citigroup’s price target would suggest a potential upside of 167.38% from the stock’s current price. Separately, StockNews.com raised Lexicon Pharmaceuticals to a “sell” rating in a […]

Jeffreyl-wade
Jpmorgan-chase-co
Pinnacle-associates-ltd
Lexicon-pharmaceuticals-company-profile
Lexicon-pharmaceuticals-stock-performance
News-ratings-for-lexicon-pharmaceuticals-daily
Internationals-ca-artal
Lexicon-pharmaceuticals-inc
Insider-transactions-at-lexicon-pharmaceuticals
Lexicon-pharmaceuticals
Securities-exchange-commission

Short Interest in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Grows By 38.0%

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) was the target of a large growth in short interest in June. As of June 30th, there was short interest totalling 14,460,000 shares, a growth of 38.0% from the June 15th total of 10,480,000 shares. Based on an average daily volume of 2,360,000 shares, the days-to-cover ratio […]

Jeffreyl-wade
Citigroup
Lexicon-pharmaceuticals-stock-down
Lexicon-pharmaceuticals-company-profile
Institutional-investors-weigh-in-on-lexicon-pharmaceuticals
Internationals-ca-artal
Sg-americas-securities
Fisher-asset-management
Lexicon-pharmaceuticals-inc
News-ratings-for-lexicon-pharmaceuticals-daily
Hudson-capital-management

Hudson Capital Management LLC Takes $37,000 Position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

Hudson Capital Management LLC bought a new stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 15,038 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Other hedge funds and other institutional […]

Montreal
Quebec
Canada
Jeffreyl-wade
Jefferies-financial-group
Barclays-plc
Citigroup
News-ratings-for-lexicon-pharmaceuticals-daily
Exchange-commission
Lexicon-pharmaceuticals-price-performance
Nasdaq

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.